At a glance
- Originator Nonindustrial source; Tulane University
- Developer Nonindustrial source
- Class Antineoplastics; Hormones
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 11 Dec 2002 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 14 Dec 2001 No-Development-Reported for Cancer in USA (Unknown route)
- 08 Feb 1995 Preclinical development for Cancer in USA (Unknown route)